Cardiac Science Inc. DFIB (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiac Science Inc. DFIB (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Fuzzy who wrote (157)	10/1/2003 11:39:47 AM
From: Skywatcher	of 174

Here's ONE big reason for the fall from 5..... so looking good for the rebound now that the selling from DURAS is OVER At Cardiac Science (DFIB:Nasdaq - commentary - research), Durus emerged as the largest institutional shareholder by March 31 with 3.29 million shares, or 4.9%, of the Irvine, Calif.-based maker of defibrillators -- the devices that monitor and correct potentially fatal irregular heartbeats. Durus raised its stake to 4.3 million shares, or 6.4%, by June 30. Then, it started selling. By Aug. 19, according to the latest data available, Durus had cut its stake to 675,000 shares, or 1%. Cardiac Science's stock is up 88% this year. CC

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next